May 25 (Reuters) - Biotron Ltd BIT.AX
* Renounceable rights offered at 2 cents per share to raise up to $1.56 million
* Net proceeds will be used to complete complementary non-clinical assays on samples from current phase 2 hiv-1 clinical trial Source text for Eikon: Further company coverage: BIT.AX